Axonal protection achieved in a model of multiple sclerosis using lamotrigine

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Axonal degeneration is a primary cause of permanent disability in multiple sclerosis (MS).
• Sodium accumulation in axons is an early step in MS-related degeneration.
• Limiting axonal sodium influx may protect axons in MS.

Purpose of the Study:

• To evaluate lamotrigine's efficacy in preventing axonal degeneration.
• To assess lamotrigine's neuroprotective effects in a chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) model of MS.

Main Methods:

• Administration of lamotrigine starting 7 days post-inoculation in CR-EAE mice.
• Assessment of neurological deficits and functional axon preservation (compound action potential area).
• Histological examination of spinal cord axonal degeneration.

Main Results:

• Lamotrigine significantly reduced neurological deficits compared to vehicle control (P<0.05).
• Treatment preserved functional axons, indicated by increased compound action potential area (P<0.05).
• Histology showed significant protection against axonal degeneration in the dorsal column (P<0.01).

Conclusions:

• Lamotrigine demonstrates potential as a neuroprotective agent in MS.
• Targeting sodium channels with lamotrigine may offer a novel therapeutic strategy for MS.
• These findings support further investigation of lamotrigine for axonal protection in multiple sclerosis.